In contrast, reducing p16INK4a expression (Figure S6G) decreased the mortality of HD NSCs, with no effect detected in C116 cells (Figure 6d), suggesting that increased p16INK4a in human HD NSCs may have deleterious effects. Here, CDKN2A is linked to Huntington disease.